Furthermore, the limit after which the tumor is considered PD-L1 positive varies greatly both among different types of cancer and in different trials; a combined positive score (CPS) of 50% is necessary for NSCLC, of 10% for bladder cancer, all the way to only 1% for gastric and cervical cancer. This evidence concerns the gene CD274 and cervical carcinoma.